Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy
Public ClinicalTrials.gov record NCT01382082. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy at Pre-Treatment, Post-Treatment, at Six Month Follow-Up, and Long-Term Follow-Ups
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Cognitive impairments in cancer patients represent an important clinical problem. Studies to date estimating prevalence of difficulties in memory, executive function, and attention deficits have been limited by small sample sizes and many have lacked healthy control groups. More information is needed on promising biomarkers and allelic variants that may help to determine the etiology of impairment, identify those most vulnerable to impairment, and develop interventions for these difficulties. This is a longitudinal observational study of cognitive function in breast cancer and lymphoma patients receiving chemotherapy to better understand the prevalence of cognitive difficulties (i.e., problems with memory, executive function, and attention) in these populations.
Study identification
- NCT ID
- NCT01382082
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,432 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 14, 2011 (Actual)
- Primary completion
- Jul 31, 2026 (Estimated)
- Completion
- Dec 31, 2026 (Estimated)
- Last update posted
- Apr 24, 2026
2011 – 2026
United States locations
- U.S. sites
- 29
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Delaware/Christiana Care NCORP | Newark | Delaware | 19713 | — |
| Delaware/Christiana Care NCORP (CHRISTIANA) | Newark | Delaware | 19718 | — |
| Heartland | Decatur | Illinois | 62526 | — |
| Kansas City Clinical Oncology Program | Prairie Village | Kansas | 66208 | — |
| Wichita NCORP | Wichita | Kansas | 67214 | — |
| Wichita | Wichita | Kansas | 67214 | — |
| Gulf South MU-NCORP | New Orleans | Louisiana | 70112 | — |
| Cancer Research Consortium of West Michigan | Grand Rapids | Michigan | 49503 | — |
| CRCWM | Grand Rapids | Michigan | 49503 | — |
| Metro Minnesota NCORP | Minneapolis | Minnesota | 55426 | — |
| Metro Minnesota Community Oncology Research Consortium | Saint Louis Park | Minnesota | 55416 | — |
| CCOP - Nevada Cancer Research Foundation | Las Vegas | Nevada | 89106 | — |
| Nevada | Las Vegas | Nevada | 89106 | — |
| Hem Onc CNY | East Syracuse | New York | 13057 | — |
| Kansas City | Rochester | New York | 14642 | — |
| University of Rochester Cancer Center | Rochester | New York | 14642 | — |
| Novant Health Cancer Institute - Kernersville | Winston-Salem | North Carolina | 27103 | — |
| Southeast Clinical Oncology Research Program | Winston-Salem | North Carolina | 27104 | — |
| Columbus NCORP | Columbus | Ohio | 43215 | — |
| Columbus | Columbus | Ohio | 43215 | — |
| Dayton Community Oncology Program | Dayton | Ohio | 45420 | — |
| Dayton | Dayton | Ohio | 45459 | — |
| Pacific Cancer Research Consortium Ncorp | Portland | Oregon | 97213 | — |
| PCRC | Portland | Oregon | 97213 | — |
| NCORP of the Carolinas | Greenville | South Carolina | 29605 | — |
| Upstate Carolina | Spartanburg | South Carolina | 29303 | — |
| Northwest (Virginia Mason) | Seattle | Washington | 98101 | — |
| Wisconsin NCORP | Marshfield | Wisconsin | 54449 | — |
| Aurora NCORP | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01382082, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 24, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01382082 live on ClinicalTrials.gov.